Covaxin trials now set to be conducted on children across six hospitals as also Glenmark plans to roll out its phase 3 trials of its nasal COVID-19 treatment

INDIA – The Indian government is aggressively trying to curb the COVID -19 pandemic with the roll out of various programs across the state. Currently the state has embarked on two programs in a bid to curb the spread of the virus with the first one being conducting vaccine trials on children (Covaxin trials) and the second one involving phase 3 trials of a nasal therapy meant to cure COVID-19 symptoms. The Covaxin trials will be conducted on 175 children aged 2-6, 6-12 and 12-18 who will be given the…

Read More